menopausal hormone therapy [topp]
Cardiovascular disease [dsyn]
utility [orgt]
Biomarkers [clna]
Stratification [resa]
menopausal hormone therapy [topp]
Continue [idcn]
Symptom Management [hlca]
Women [popg]
Benefit [qnco]
Risks [qlco]
Challenge [clna]
Hormone Therapy [topp]
Hormone Therapy [topp]
effective [qlco]
strategy [menp]
Vasomotor [ftcn]
symptoms [ftcn]
Clinical Trials, Randomized [inpr, resa]
Unfavorable [qlco]
Balance [orgf]
Benefits [qnco]
Women [popg]
Trial [resa]
Suggest [idcn]
classify [clas]
Women [popg]
worse [qlco]
Hormone Therapy [topp]
Stratification [resa]
Content [menp]
Trial [resa]
Initiative [menp]
WHI [inpr]
Heart study [diap]
Estrogen Replacement [topp]
Progestin [horm, phsu, strd]
Suggest [idcn]
clinical characteristics [clna]
Biomarkers [clna]
Genomic [gngm]
Marker [clna]
Interactions, Gene-Environment [genf]
Personalized [qlco]
Approach [spco]
Prediction [idcn]
cardiovascular events [fndg]
Women [popg]
Hormone Therapy [topp]
Available [ftcn]
Suggest [idcn]
Several [qnco]
Characteristics [qlco]
Women [popg]
Optimal [qlco]
Hormone Therapy [topp]
Young [tmco]
Age [orga]
Onset [qlco]
Menopause [phsf]
Favorable [qlco]
Lipid [lipd]
Profile [lbpr]
Cholesterol, LDL [bacs, strd]
mg dl [qnco]
HDL/cholesterol ratio [lbpr]
2 5 [qnco]
absence [qnco]
Metabolic syndrome [dsyn]
absence [qnco]
Factor V Leiden genotype [lbpr]
Identification [menp]
Characteristics [qlco]
Area [geoa]
Active [ftcn]
Investigation [hlca]
Addition [ftcn]
Women [popg]
High Risk [qlco]
Venous Thromboembolism [patf]
Systemic Therapy [topp]
Hormone [horm]
Choose [acty]
Transdermal [ftcn]
Oral Route [ftcn]
Delivery [topp]
summary [inpr]
Personalized Medicine [topp]
i e [diap, inpr]
Specific [qlco]
Biological Profile [cnce]
Guide [prog]
choice [inbe]
treatment [ftcn]
Highly [qlco]
Relevant [qlco]
Decision Making [menp]
Hormone Therapy [topp]
promise [idcn]
Improved [qlco]
Treatment Efficacy [qlco]
Safety [hcpp]
American [popg]
Association [menp]
Chemistry, Clinical [bmod]
